Endothelial cell therapy may play role in cornea donation

[ad_1]

August 15, 2021

1 min read


We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].

The IOTA study and a phase 2 risuteganib trial led recent cornea/external disease coverage on Healio/OSN.

Check out some of the top-performing items below.

IOTA study: One donor cornea may help treat hundreds of patients

Instead of using one donor cornea for one patient, endothelial cell therapy may allow tissue from one donor to be used by as many as 100 patients. Read more.

VIDEO: Donnenfeld discusses risuteganib for dry eye disease

Eric D. Donnenfeld, MD, discusses the FDA phase 2 trial of risuteganib in patients with dry eye disease. Watch here.

Diagnosis key for proper treatment of infectious keratitis

Many cases of Acanthamoeba keratitis are misdiagnosed. Read more.

Compounded cyclosporine may be option for dry eye treatment

Klarity-C was a suitable alternative treatment for patients with dry eye disease, according to a study published in Clinical Ophthalmology. Read more.

Artificial endothelial layer reduces corneal edema, pain

A polymer film implant attached to the posterior corneal surface can treat corneal edema secondary to endothelial dysfunction and may be an alternative to endothelial keratoplasty. Read more.

[ad_2]

Source link

Kathy Laura

Leave a Reply

Your email address will not be published.